Lataa...
Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data
BACKGROUND. Clinical features of patients with castration-resistant prostate cancer (CRPC) are characterized by a high incidence of bone metastases, which are associated with impairment of quality of life, pain, skeletal-related events (SREs), and a negative impact on prognosis. Advances in the unde...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AlphaMed Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4200991/ https://ncbi.nlm.nih.gov/pubmed/25232039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0472 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|